메뉴 건너뛰기




Volumn 29, Issue 7, 2008, Pages 1389-1394

Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: A single-center experience

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR;

EID: 49749114862     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1070     Document Type: Article
Times cited : (116)

References (31)
  • 1
    • 16344362182 scopus 로고    scopus 로고
    • Outcome of endovascular treatment in symptomatic intracranial vascular stenosis
    • Suh DC, Kim SJ, Lee DH, et al. Outcome of endovascular treatment in symptomatic intracranial vascular stenosis. Korean J Radiol 2005;6:1-7
    • (2005) Korean J Radiol , vol.6 , pp. 1-7
    • Suh, D.C.1    Kim, S.J.2    Lee, D.H.3
  • 2
    • 33745780138 scopus 로고    scopus 로고
    • Neuroform in-stent stenosis: Incidence, natural history, and treatment strategies
    • Fiorella D, Albuquerque FC, Woo H, et al. Neuroform in-stent stenosis: incidence, natural history, and treatment strategies. Neurosurgery 2006;59:34-42
    • (2006) Neurosurgery , vol.59 , pp. 34-42
    • Fiorella, D.1    Albuquerque, F.C.2    Woo, H.3
  • 3
    • 2542580323 scopus 로고    scopus 로고
    • Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): Study results
    • SSYLVIA Study Investigators, Epub Apr 22
    • SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388 -92. Epub 2004 Apr 22.
    • (2004) Stroke 2004;35:1388 -92
  • 4
    • 33745965540 scopus 로고    scopus 로고
    • Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events
    • Ries T, Buhk JH, Kucinski T, et al. Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 2006;37:1816-21
    • (2006) Stroke , vol.37 , pp. 1816-1821
    • Ries, T.1    Buhk, J.H.2    Kucinski, T.3
  • 5
    • 33645754725 scopus 로고    scopus 로고
    • Endovascular treatment of unruptured intracranial aneurysms: Occurrence of thromboembolic events
    • Grunwald IQ, Papanagiotou P, Politi M, et al. Endovascular treatment of unruptured intracranial aneurysms: occurrence of thromboembolic events. Neurosurgery 2006;58:612-18
    • (2006) Neurosurgery , vol.58 , pp. 612-618
    • Grunwald, I.Q.1    Papanagiotou, P.2    Politi, M.3
  • 6
    • 7844220998 scopus 로고    scopus 로고
    • Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: The full anticoagulation versus aspirin and ticlopidine (fantastic) study
    • Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation 1998;98:1597-603
    • (1998) Circulation , vol.98 , pp. 1597-1603
    • Bertrand, M.E.1    Legrand, V.2    Boland, J.3
  • 7
    • 0034691260 scopus 로고    scopus 로고
    • Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans
    • Cadroy Y, Bossavy JP, Thalamas C, et al. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation 2000;101:2823-28
    • (2000) Circulation , vol.101 , pp. 2823-2828
    • Cadroy, Y.1    Bossavy, J.P.2    Thalamas, C.3
  • 8
    • 12844278540 scopus 로고    scopus 로고
    • Oral antiplatelet therapy and percutaneous coronary intervention
    • Yan BP, Clark DJ, Ajani AE. Oral antiplatelet therapy and percutaneous coronary intervention. Expert Opin Pharmacother 2005;6:3-12
    • (2005) Expert Opin Pharmacother , vol.6 , pp. 3-12
    • Yan, B.P.1    Clark, D.J.2    Ajani, A.E.3
  • 9
    • 0033806824 scopus 로고    scopus 로고
    • Stent thrombosis: Historical perspectives and current trends
    • Cutlip DE. Stent thrombosis: historical perspectives and current trends. J Thromb Thrombolysis 2000;10:89-101
    • (2000) J Thromb Thrombolysis , vol.10 , pp. 89-101
    • Cutlip, D.E.1
  • 10
    • 33749438519 scopus 로고    scopus 로고
    • Aspirin and clopidogrel resistance: Consideration and management
    • Gurbel PA, Tantry US. Aspirin and clopidogrel resistance: consideration and management. J Interv Cardiol 2006;19:439-48
    • (2006) J Interv Cardiol , vol.19 , pp. 439-448
    • Gurbel, P.A.1    Tantry, U.S.2
  • 11
    • 11844256436 scopus 로고    scopus 로고
    • Variability in platelet responsiveness to clopidogrel among 544 individuals
    • Serebruany VL, Steinhubl SR, Berger PB, et al. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45:246-51
    • (2005) J Am Coll Cardiol , vol.45 , pp. 246-251
    • Serebruany, V.L.1    Steinhubl, S.R.2    Berger, P.B.3
  • 12
    • 33947328091 scopus 로고    scopus 로고
    • Thienopyridines in cardiovascular disease: Focus on clopidogrel resistance
    • Siller-Matula J, Schror K, Wojta J, et al. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance. Thromb Haemost 2007;97:385-93
    • (2007) Thromb Haemost , vol.97 , pp. 385-393
    • Siller-Matula, J.1    Schror, K.2    Wojta, J.3
  • 13
    • 33646441600 scopus 로고    scopus 로고
    • Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness
    • von Beckerath N, Pogatsa-Murray G, Wieczorek A, et al. Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness. Thromb Haemost 2006;95:910-11
    • (2006) Thromb Haemost , vol.95 , pp. 910-911
    • von Beckerath, N.1    Pogatsa-Murray, G.2    Wieczorek, A.3
  • 14
    • 33750083316 scopus 로고    scopus 로고
    • A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention
    • Epub Aug 28
    • van Werkum JW, van der Stelt CA, Seesing TH, et al. A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention. J Thromb Haemost 2006;4:2516 -18. Epub 2006 Aug 28
    • (2006) J Thromb Haemost 2006;4:2516 -18
    • van Werkum, J.W.1    van der Stelt, C.A.2    Seesing, T.H.3
  • 15
    • 33845474736 scopus 로고    scopus 로고
    • Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study
    • Epub Mar 24
    • Malinin A, Pokov A, Spergling M, et al. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Thromb Res 2007;119:277-84. Epub 2006 Mar 24
    • (2006) Thromb Res 2007 , vol.119 , pp. 277-284
    • Malinin, A.1    Pokov, A.2    Spergling, M.3
  • 16
    • 84989198039 scopus 로고    scopus 로고
    • Determination of individual response to aspirin therapy using the accumetrics Ultegra RPFA-ASA system
    • Coleman JL, Wang JC, Simon DI. Determination of individual response to aspirin therapy using the accumetrics Ultegra RPFA-ASA system. Point of Care 2004;3:77-82
    • (2004) Point of Care , vol.3 , pp. 77-82
    • Coleman, J.L.1    Wang, J.C.2    Simon, D.I.3
  • 17
    • 2942555599 scopus 로고    scopus 로고
    • Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer
    • Malinin A, Spergling M, Muhlestein B, et al. Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer. Blood Coagul Fibrinolysis 2004;15:295-301
    • (2004) Blood Coagul Fibrinolysis , vol.15 , pp. 295-301
    • Malinin, A.1    Spergling, M.2    Muhlestein, B.3
  • 18
    • 9644281092 scopus 로고    scopus 로고
    • Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting
    • Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res 2005;115:101-08
    • (2005) Thromb Res , vol.115 , pp. 101-108
    • Angiolillo, D.J.1    Fernandez-Ortiz, A.2    Bernardo, E.3
  • 20
    • 34249990913 scopus 로고    scopus 로고
    • Clopidogrel resistance?
    • Gurbel PA, Tantry US. Clopidogrel resistance? Thromb Res 2006;120:311-21
    • (2006) Thromb Res , vol.120 , pp. 311-321
    • Gurbel, P.A.1    Tantry, U.S.2
  • 21
    • 0035908781 scopus 로고    scopus 로고
    • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
    • Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33
    • (2001) Lancet , vol.358 , pp. 527-533
    • Mehta, S.R.1    Yusuf, S.2    Peters, R.J.3
  • 22
    • 0037145863 scopus 로고    scopus 로고
    • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
    • Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20
    • (2002) JAMA , vol.288 , pp. 2411-2420
    • Steinhubl, S.R.1    Berger, P.B.2    Mann, J.T.3
  • 23
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502
    • (2001) N Engl J Med , vol.345 , pp. 494-502
    • Yusuf, S.1    Zhao, F.2    Mehta, S.R.3
  • 24
    • 18144371221 scopus 로고    scopus 로고
    • The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting
    • Gurbel PA, Bliden KP, Hayes KM, et al. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 2005;45:1392-96
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1392-1396
    • Gurbel, P.A.1    Bliden, K.P.2    Hayes, K.M.3
  • 25
    • 33751078322 scopus 로고    scopus 로고
    • Clopidogrel response variability, resistance, or both?
    • Wiviott SD. Clopidogrel response variability, resistance, or both? Am J Cardiol 2006;98:18N-24N
    • (2006) Am J Cardiol , vol.98
    • Wiviott, S.D.1
  • 26
    • 34248397644 scopus 로고    scopus 로고
    • A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days
    • von Beckerath N, Kastrati A, Wieczorek A, et al. A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. Eur Heart J 2007;28:1814-19
    • (2007) Eur Heart J , vol.28 , pp. 1814-1819
    • von Beckerath, N.1    Kastrati, A.2    Wieczorek, A.3
  • 27
    • 36148983750 scopus 로고    scopus 로고
    • Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15. Epub 2007 Nov 4
    • Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15. Epub 2007 Nov 4
  • 28
    • 33645052218 scopus 로고    scopus 로고
    • ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention)
    • Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:e166-286
    • (2006) Circulation , vol.113
    • Smith Jr, S.C.1    Feldman, T.E.2    Hirshfeld Jr, J.W.3
  • 29
    • 34447282174 scopus 로고    scopus 로고
    • Clopidogrel resistance: Role of body mass and concomitant medications
    • Feher G, Koltai K, Alkonyi B, et al. Clopidogrel resistance: role of body mass and concomitant medications. Int J Cardiol 2006;120:188-92
    • (2006) Int J Cardiol , vol.120 , pp. 188-192
    • Feher, G.1    Koltai, K.2    Alkonyi, B.3
  • 30
    • 0038649988 scopus 로고    scopus 로고
    • Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
    • Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-13
    • (2003) Circulation , vol.107 , pp. 2908-2913
    • Gurbel, P.A.1    Bliden, K.P.2    Hiatt, B.L.3
  • 31
    • 19644372173 scopus 로고    scopus 로고
    • Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention
    • Hochholzer W, Trenk D, Frundi D, et al. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation 2005;111:2560-64
    • (2005) Circulation , vol.111 , pp. 2560-2564
    • Hochholzer, W.1    Trenk, D.2    Frundi, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.